Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership731,609 shares
Latest Disclosed Value $ 96,382,170
Victory Capital Management Inc reports 487.35% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 731,609 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $96,382,170 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 124,560 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 487.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 731,609 607,049 487.35 96,382 445.58 0.0463
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 124,560 -285 -0.23 17,666 0.80 0.0100
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 124,845 31,981 34.44 17,526 50.15 0.0102
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 92,864 955 1.04 11,672 14.83 0.0075
2025-05-02 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 91,909 -97,987 -51.60 10,165 -60.78 0.0104
2025-02-06 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 189,896 -14,309 -7.01 25,921 10.17 0.0255
2024-11-05 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 204,205 66,662 48.47 23,529 24.26 0.0227
2024-08-05 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 137,543 1,676 1.23 18,936 1.05 0.0190
2024-05-03 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 135,867 18,646 15.91 18,739 21.32 0.0183
2024-02-05 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 117,221 47,389 67.86 15,445 96.60 0.0162
2023-11-06 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,832 463 0.67 7,856 20.10 0.0090
2023-07-27 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,369 -11,024 -13.71 6,541 -19.61 0.0072
2023-05-02 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 80,393 -32,945 -29.07 8,137 -39.89 0.0091
2023-04-25 2022-12-31 13F/A-3 NEUROCRINE BIOSCIENCES COM 64125C109 113,338 15,478 15.82 13,537 30.24 0.0156
2023-03-10 2022-12-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 113,338 15,478 13,537 0.0148
2023-02-10 2022-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 113,338 15,478 13,537 0.0093
2023-02-09 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 100,541 2,681 11,153 0.0076
2022-11-02 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 97,860 12,535 14.69 10,394 24.97 0.0121
2022-08-01 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 85,325 -695 -0.81 8,317 7.40 0.0095
2022-05-04 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 86,020 69,412 417.94 7,744 447.28 0.0077
2022-02-07 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,608 -4,238 -20.33 1,415 -29.21 0.0013
2021-11-02 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,846 -18,334 -46.79 1,999 -47.57 0.0020
2021-08-03 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 39,180 -1,985 -4.82 3,813 -4.75 0.0037
2021-05-04 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 41,165 -342,211 -89.26 4,003 -89.11 0.0041
2021-02-01 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 383,376 -318,735 -45.40 36,747 -45.57 0.0409
2020-11-09 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 702,111 59,279 9.22 67,516 -13.91 0.0867
2020-08-07 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 642,832 69,631 12.15 78,426 58.08 0.1062
2020-05-12 2020-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 573,201 -66,500 -10.40 49,611 -27.85 0.0832
2020-05-04 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 573,201 -66,500 49,611 54,294.1982
2020-02-06 2019-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 639,701 199,705 45.39 68,762 73.43 0.0835
2020-02-04 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 629,446 189,450 62,995 75,511.5173
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 439,996 172,526 64.50 39,648 75.57 0.0510
2019-08-15 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 267,470 -268,630 -50.11 22,583 -52.19 0.0456
2019-05-03 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 536,100 -17,085 -3.09 47,231 19.56 0.1075
2019-05-02 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 553,185 -51,950 -8.58 39,503 -46.91 0.0992
2019-02-05 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 553,185 -51,950 39,503
2018-11-01 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 605,135 228,163 60.53 74,402 100.90 0.1535
2018-08-02 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 376,972 -192,628 -33.82 37,034 -21.60 0.0788
2018-05-04 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 569,600 568,940 86,203.03 47,237 92,521.57 0.1030
2018-02-01 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 660 0 0.00 51 27.50 0.0001
2017-10-27 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 660 0 0.00 40 33.33 0.0001
2017-08-07 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 660 11 1.69 30 7.14 0.0001
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 649 -16,400 -96.19 28 -95.76 0.0001
2017-02-09 2016-12-31 13F NEUROCRINE BIOSCIENCES INC COM COM 64125C109 17,049 36 0.21 660 -23.34 0.0017
2016-11-02 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,013 16,441 2,874.30 861 3,211.54 0.0024
2016-08-09 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 572 74 14.86 26 30.00 0.0001
2016-05-17 2016-03-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 498 35 7.56 20 -23.08 0.0001
2016-05-12 2016-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 498 0 20 0.0001
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 498 20
2016-02-10 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 463 25 5.71 26 52.94 0.0001
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 438 34 8.42 17 -10.53 0.0001
2015-08-14 2015-06-30 13F/A-01 NEUROCRINE BIOSCIENCES COM 64125C109 404 404 19 0.0001
2015-08-07 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 404 19
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.